NCT07539441 A Study of Mirdametinib in People With Central Nervous System Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05308407 POWER UP: Participating Online While Exercising to Recover Using Play Status TERMINATED Phase NA
NCT05235074 OH2 Oncolytic Viral Therapy in Central Nervous System Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05081180 Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03050450 Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors Status TERMINATED Phase PHASE1
NCT01985451 Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma (PCNSL) Status UNKNOWN Phase PHASE2
NCT01735747 Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma Status UNKNOWN Phase PHASE2
NCT01135563 Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours Status COMPLETED Phase PHASE1
NCT01067196 Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and Neck Status COMPLETED Phase N/A
NCT01052363 OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas Status WITHDRAWN Phase PHASE1
NCT00945828 Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors Status COMPLETED Phase NA
NCT00899834 DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma Status COMPLETED Phase N/A
NCT00876993 Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors Status COMPLETED Phase PHASE1
NCT00607984 Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors Status UNKNOWN Phase NA
NCT00477503 Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA Status TERMINATED Phase PHASE1
NCT00400816 Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma Status COMPLETED Phase PHASE2